| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6189359 | Brachytherapy | 2013 | 6 Pages |
Abstract
With a minimum followup of 10 years, results are excellent and do not differ for LR or IR prostate cancer patients. HR patients are a very heterogeneous group, and excellent results can still be achieved for HR patients with only one HR feature.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Carlos Vargas, Douglas Swartz, Apoorva Vashi, Mark Blasser, Ali Kasareian, Jamie Cesaretti, Kathleen Kiley, Mitchell Terk,